Medication | Values | P-value | |
---|---|---|---|
SPMs (N = 23) | Placebo (N = 28) | ||
Concomitant medication at baseline, n (%) | |||
At baseline | 10 (43.48) | 7 (25.00) | 0.164 (1) |
At week 4 | 2 (8.70) | 2 (7.14) | 0.383 (2) |
At week 8 | 2 (8.70) | 2 (7.14) | 0.383 (2) |
At week 12 | 3 (13.04) | 4 (14.29) | 0.313 (2) |
Rescue medication, n (%) | |||
At week 4 | 0 (0.00) | 0 (0.00) | |
At week 8 | 0 (0.00) | 0 (0.00) | |
At week 12 | 0 (0.00) | 0 (0.00) | |
Anti-inflammatory medication, n (%) | |||
At week 24 | 4 (17.39) | 4 (14.29) | 0.285 (2) |